The Vigabatrin REMS Program is needed by the FDA to ensure informed risk-benefit decisions before initiating treatment, and to ensure appropriate use of vigabatrin while individuals are dealt with. It is not possible for your healthcare provider to recognize when vision loss will certainly occur.
It is advised that your doctor test your (or your child's) vision before or within 4 weeks after starting SABRIL and at least every 3 months throughout treatment till SABRIL is stopped. If you or your youngster have any kind of side result that troubles you or that does not go away, tell your healthcare service provider.
Inform your healthcare provider if you are pregnant or intend to obtain pregnant. If vision testing can not be done, your healthcare provider may continue suggesting SABRIL, but will certainly not be able to look for any vision loss. Your health care company might stop recommending SABRIL for you (or your youngster)if vision examinations are not done frequently.